Initiating angiotensin converting enzyme inhibitors in mild to moderate heart failure in general practice: randomised, placebo controlled trial.
作者信息
Lough M, Cleland J, Langan J, Cowley A, Wade A
机构信息
Airdrie Health Centre, Monkscourt Avenue, Airdrie ML6 0JU.
出版信息
BMJ. 1998 Nov 14;317(7169):1352-3. doi: 10.1136/bmj.317.7169.1352.
Abstract
摘要
相似文献
1
Initiating angiotensin converting enzyme inhibitors in mild to moderate heart failure in general practice: randomised, placebo controlled trial.在全科医疗中对轻至中度心力衰竭患者起始使用血管紧张素转换酶抑制剂：随机、安慰剂对照试验。
BMJ. 1998 Nov 14;317(7169):1352-3. doi: 10.1136/bmj.317.7169.1352.
2
Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.慢性心力衰竭患者停用血管紧张素转换酶抑制剂的临床后果：喹那普利的双盲、安慰剂对照研究。喹那普利心力衰竭试验研究者。
J Am Coll Cardiol. 1993 Nov 15;22(6):1557-63. doi: 10.1016/0735-1097(93)90578-o.
3
A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.一项关于喹那普利治疗轻度慢性心力衰竭的多中心、双盲、安慰剂对照试验。
Eur Heart J. 1993 Mar;14(3):403-9. doi: 10.1093/eurheartj/14.3.403.
4
Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure.
Circulation. 1992 Dec;86(6):1800-9. doi: 10.1161/01.cir.86.6.1800.
5
Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril.
Am Heart J. 1992 May;123(5):1433-8. doi: 10.1016/0002-8703(92)91066-a.
6
Quinapril in chronic heart failure.
Am J Hypertens. 1990 Nov;3(11):283S-287S. doi: 10.1093/ajh/3.11s.283s.
7
The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure.血管紧张素转换酶抑制剂在治疗充血性心力衰竭中对运动能力的影响。
J Cardiovasc Pharmacol. 1990;15 Suppl 2:S41-6. doi: 10.1097/00005344-199000152-00008.
8
Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.使用喹那普利抑制血管紧张素转换酶可改善冠心病患者的内皮血管舒缩功能障碍。TREND（逆转内皮功能障碍试验）研究。
Circulation. 1996 Aug 1;94(3):258-65. doi: 10.1161/01.cir.94.3.258.
9
Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.喹那普利在健康志愿者、高血压患者及充血性心力衰竭患者中的临床药理学。
Angiology. 1989 Apr;40(4 Pt 2):360-9. doi: 10.1177/000331978904000405.
10
[Angiotensin-converting enzyme, quinapril, in treating chronic cardiac failure].[血管紧张素转换酶抑制剂喹那普利治疗慢性心力衰竭]
Ter Arkh. 2003;75(1):51-5.
引用本文的文献
1
Taking heart failure seriously.认真对待心力衰竭。
BMJ. 2000 Nov 4;321(7269):1095-6. doi: 10.1136/bmj.321.7269.1095.
2
3
Audit of use of ACE inhibitors and monitoring in general practice. Guidelines on monitoring, on their own, are not sufficient.
BMJ. 1999 Jun 19;318(7199):1697. doi: 10.1136/bmj.318.7199.1697.
本文引用的文献
1
Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?为什么全科医生在心力衰竭治疗中对血管紧张素转换酶抑制剂的使用不足？
Int J Cardiol. 1997 Mar;59(1):7-10. doi: 10.1016/s0167-5273(96)02904-x.
2
Prevalence, aetiology and management of heart failure in general practice.全科医疗中心力衰竭的患病率、病因及管理
Br J Gen Pract. 1996 Feb;46(403):77-9.
3
Stability of plasma concentrations of N and C terminal atrial natriuretic peptides at room temperature.N 末端和 C 末端心房利钠肽血浆浓度在室温下的稳定性。
Heart. 1996 Apr;75(4):410-3. doi: 10.1136/hrt.75.4.410.
4
Evidence of inadequate investigation and treatment of patients with heart failure.心力衰竭患者调查与治疗不足的证据。
Br Heart J. 1994 Jun;71(6):584-7. doi: 10.1136/hrt.71.6.584.
5
ACE inhibitors for the prevention and treatment of heart failure: why are they 'under-used'?用于预防和治疗心力衰竭的血管紧张素转换酶抑制剂：为何“使用不足”？
J Hum Hypertens. 1995 Jun;9(6):435-42.
6
The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study.充血性心力衰竭治疗对血浆心钠素浓度的影响：一项纵向研究。
Br Heart J. 1988 Feb;59(2):207-11. doi: 10.1136/hrt.59.2.207.
Zotero 插件